Safety Profile

MOTS-c Side Effects & Safety

MOTS-c has limited human safety data from early-stage clinical trials. Preclinical toxicology shows a clean profile.

Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.

Side effects by severity

Common1 effect

Injection site reactions

Mild and transient.

Uncommon2 effects

Transient fatigue

Reported in early doses.

Headache

Mild; typically resolves.

Contraindications

Pregnancy
Active malignancy (investigational)
Known hypersensitivity

Drug interactions

Limited published data
Theoretical interaction with other AMPK activators (metformin)

Special populations

Not FDA approved. Insufficient data for pregnancy, pediatric, or elderly use.

Safety summary

MOTS-c is under active Phase I/II investigation. Preclinical data shows excellent tolerability; human data is still being collected.

Frequently asked

Is MOTS-c safe to combine with metformin?

Both activate AMPK through different routes. Theoretical additive effects exist but clinical interaction data is lacking.